Whole-brain radiotherapy in the management of brain metastasis

被引：354

作者：

Khuntia, D

Brown, P

Li, J

Mehta, MP

机构：

[1] Univ Wisconsin, Dept Human Oncol, Madison, WI 53792 USA

[2] Mayo Clin, Rochester, MN USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 08期

关键词：

D O I：

10.1200/JCO.2005.04.6185

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Brain metastases are an important cause of morbidity and mortality, afflicting nearly 170,000 Americans annually. The prognosis for these patients is poor, with median survival times measured in months. In this review article, we present the standard treatment approach of whole-brain radiotherapy and discuss new directions, including the role of chemical modifiers and the management and prevention of neurocognitive deficits.

引用

收藏

页码：1295 / 1304

页数：10

相关论文

共 109 条

[1] A phase II trial of temozolomide for patients with recurrent or progressive brain metastases [J].

Abrey, LE ;

Olson, JD ;

Raizer, JJ ;

Mack, M ;

Rodavitch, A ;

Boutros, DY ;

Malkin, MG .

JOURNAL OF NEURO-ONCOLOGY, 2001, 53 (03) :259-265

[2] Temozolomide for the treatment of brain metastases associated with metastatic melanoma: A phase II study [J].

Agarwala, SS ;

Kirkwood, JM ;

Gore, M ;

Dreno, B ;

Thatcher, N ;

Czarnetski, B ;

Atkins, M ;

Buzaid, A ;

Skarlos, D ;

Rankin, EM .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2101-2107

[3] Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial [J].

Andrews, DW ;

Scott, CB ;

Sperduto, PW ;

Flanders, AE ;

Gaspar, LE ;

Schell, MC ;

Werner-Wasik, M ;

Demas, W ;

Ryu, J ;

Bahary, JP ;

Souhami, L ;

Rotman, M ;

Mehta, MP ;

Curran, WJ .

LANCET, 2004, 363 (9422) :1665-1672

[4] Phase II Randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases [J].

Antonadou, D ;

Paraskevaidis, M ;

Sarris, G ;

Coliarakis, N ;

Economou, I ;

Karageorgis, P ;

Throuvalas, N .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) :3644-3650

[5]

Aoyama H, 2004, J CLIN ONCOL, V22, p108S

[6]

ARBIT E, 1995, CANCER, V76, P765, DOI 10.1002/1097-0142(19950901)76:5<765::AID-CNCR2820760509>3.0.CO

[7]

2-E

[8] A critical review of the clinical effects of therapeutic irradiation damage to the brain: The roots of controversy [J].

Armstrong, CL ;

Gyato, K ;

Awadalla, AW ;

Lustig, R ;

Tochner, ZA .

NEUROPSYCHOLOGY REVIEW, 2004, 14 (01) :65-86

[9] Radiation induced CNS toxicity - molecular and cellular mechanisms [J].

Belka, C ;

Budach, W ;

Kortmann, R ;

Bamberg, M .

BRITISH JOURNAL OF CANCER, 2001, 85 (09) :1233-1239

[10] Symptom response after palliative radiotherapy for patients with brain metastases [J].

Bezjak, A ;

Adam, J ;

Barton, R ;

Panzarella, T ;

Laperriere, N ;

Wong, CS ;

Mason, W ;

Buckley, C ;

Levin, W ;

McLean, M ;

Wu, JSY ;

Sia, M ;

Kirkbride, P .

EUROPEAN JOURNAL OF CANCER, 2002, 38 (04) :487-496

← 1 2 3 4 5 6 7 8 9 10 →